全球COVID-19大流行中的整形外科实践:印度共识
该共识由印度整形与重建外科专家基于印度医学研究理事会(ICMR)等政府及非政府来源的COVID-19指南制定。将需整形外科服务的患者按干预紧迫性分为四类:急性(24-48小时内需干预)、亚急性(未来3-10天)、慢性(最好一个月内)、晚期(未来六个月内)。分类依据为手术干预的紧迫性和优先级与手术及意外暴露COVID-19阳性患者风险的权衡。结论指出当前缺乏针对大多数整形外科患者的明确指南,提出「延迟保守治疗」策略在当前情景下效果最佳。
要点
- 急性病例需在24-48小时内干预,亚急性在3-10天内,慢性最好一个月内,晚期在六个月内。
- 分类依据为手术干预的紧迫性和优先级与手术及意外暴露COVID-19阳性患者风险的权衡。
- 共识基于ICMR等来源的COVID-19指南及印度主要整形与重建外科中心的汇总经验制定。
- 作者认为「延迟保守治疗」策略在当前COVID-19大流行情景下效果最佳。
适用人群与场景
- 需要整形外科服务的患者,包括择期或急诊场景下COVID-19疑似或感染患者。
诊断标准与关键阈值
- 急性病例:需在24-48小时内进行干预。
- 亚急性病例:需在未来3-10天内进行干预。
- 慢性病例:最好在一个月内进行整形外科手术。
- 晚期病例:需在未来六个月内进行手术。
处置流程与药物剂量
- 根据手术干预的紧迫性和优先级与手术及意外暴露COVID-19阳性患者风险之间的权衡,将患者分为急性、亚急性、慢性和晚期四类。
- 针对四类患者分别制定单独的指南。
研究设计与关键结果
- 共识指南基于ICMR等政府及非政府来源的COVID-19指南制定,并将整形外科问题分为四组,每组制定单独指南。
证据类型、等级与局限
- 证据类型:共识指南。
- 制定方法:基于ICMR等政府及非政府来源的COVID-19指南及印度主要整形与重建外科中心的汇总经验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为「延迟保守治疗」策略在当前COVID-19大流行情景下效果最佳。
- 按急性(24-48小时)、亚急性(3-10天)、慢性(一个月内)、晚期(六个月内)分层安排整形外科干预时机,以平衡患者风险与手术团队COVID-19暴露风险。
指南或共识出处
- 印度整形与重建外科COVID-19共识指南,基于印度医学研究理事会(ICMR)建议及印度主要中心经验。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The COVID-19 pandemic having spread globally has profound implications on medical and surgical care, which is given by the health care providers. At this time, though there are guidelines and recommendations for medical management of these patients, there is a lack of guidance on how a plastic surgeon should approach the COVID-19 suspect or infected patient who presents either in an elective or emergency setting. We aim to provide a consensus guideline based on the current recommendations of the Indian Council of Medical Research (ICMR) and the pooled experience of the major centers performing plastic and reconstructive surgery in India.
METHODS: The current guidelines and recommendations on the COVID-19 pandemic were studied from both government and nongovernment sources including ICMR. The problems in the specialty of plastic surgery were categorized into four groups and for each group, separate and individual guidelines have been formulated.
GUIDELINES: Consensus guidelines have been formulated for the specialty of Plastic and Reconstructive surgery. The patients requiring plastic surgery service have been categorized into four groups of acute, subacute, chronic, and late category. Acute cases are the ones who require intervention within 24-48 h. Subacute cases are the ones who require intervention in the next 3-10 days, while the chronic are the ones who need plastic surgery preferably within a month. The late category are the ones who need surgery within the next six months. This has been done based on the urgency and priority of surgical intervention titrated against the risks of operating and inadvertently acquiring the exposure of COVID-19-positive patients.
CONCLUSION: Currently, in the wake of COVID-19 pandemic, there are no clear guidelines specific to the vast majority of patients who come for a plastic surgery intervention. This puts the patients at risk due to the impending plastic surgery problem while at the same time it poses a risk of exposure to COVID-19 for the surgical team. Consensus guidelines are presented, to steer the plastic surgeon in his work, in the wake of COVID-19 crisis. The guidelines are based on firm scientific evidence from the reputed research and regulatory bodies and have been made in consonance with plastic surgery experts around the country, so that these practices best suit the needs of the patients, while being mindful of resource limitations and infection risks. The approach of "delayed conservative treatment" works best in the present case scenario.
参考来源
- Agarwal R, Singhal M, Shankhdhar VK, et al. Plastic surgery practices amidst global COVID-19 pandemic: Indian consensus. J Plast Reconstr Aesthet Surg. 2020. PMID: 32878726. doi:10.1016/j.bjps.2020.08.003
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。